Eli Lilly Current Ratio 2006-2019 | LLY

Current and historical current ratio for Eli Lilly (LLY) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Eli Lilly current ratio for the three months ending June 30, 2019 was 1.14.
Eli Lilly Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $13.46B $11.86B 1.14
2019-03-31 $12.60B $11.24B 1.12
2018-12-31 $20.55B $11.89B 1.73
2018-09-30 $20.69B $10.83B 1.91
2018-06-30 $18.33B $13.06B 1.40
2018-03-31 $16.26B $11.55B 1.41
2017-12-31 $19.20B $14.54B 1.32
2017-09-30 $17.43B $12.67B 1.38
2017-06-30 $15.75B $11.30B 1.39
2017-03-31 $12.98B $10.45B 1.24
2016-12-31 $15.10B $10.99B 1.38
2016-09-30 $13.39B $8.27B 1.62
2016-06-30 $12.98B $8.40B 1.55
2016-03-31 $11.72B $7.34B 1.60
2015-12-31 $12.57B $8.23B 1.53
2015-09-30 $12.57B $8.30B 1.51
2015-06-30 $12.35B $8.23B 1.50
2015-03-31 $11.74B $8.34B 1.41
2014-12-31 $11.93B $9.74B 1.23
2014-09-30 $12.11B $7.58B 1.60
2014-06-30 $13.16B $7.42B 1.77
2014-03-31 $13.04B $6.63B 1.97
2013-12-31 $13.11B $8.92B 1.47
2013-09-30 $13.20B $8.08B 1.64
2013-06-30 $12.64B $8.41B 1.50
2013-03-31 $12.33B $7.59B 1.62
2012-12-31 $13.04B $8.39B 1.55
2012-09-30 $14.04B $6.96B 2.02
2012-06-30 $12.31B $6.61B 1.86
2012-03-31 $12.60B $6.55B 1.92
2011-12-31 $14.25B $8.93B 1.60
2011-09-30 $14.57B $8.22B 1.77
2011-06-30 $14.95B $8.62B 1.73
2011-03-31 $15.35B $7.65B 2.01
2010-12-31 $14.84B $6.93B 2.14
2010-09-30 $14.18B $6.10B 2.33
2010-06-30 $12.47B $6.33B 1.97
2010-03-31 $12.25B $5.66B 2.17
2009-12-31 $12.49B $6.57B 1.90
2009-09-30 $11.81B $6.07B 1.95
2009-06-30 $10.94B $6.99B 1.57
2009-03-31 $10.26B $7.36B 1.40
2008-12-31 $12.45B $13.11B 0.95
2008-09-30 $12.95B $6.51B 1.99
2008-06-30 $12.68B $5.26B 2.41
2008-03-31 $12.49B $4.16B 3.00
2007-12-31 $12.32B $5.44B 2.27
2007-09-30 $10.45B $4.07B 2.57
2007-06-30 $9.56B $4.55B 2.10
2007-03-31 $9.25B $4.15B 2.23
2006-12-31 $9.69B $5.09B 1.91
2006-09-30 $9.77B $3.88B 2.52
2006-06-30 $10.59B $4.65B 2.28
2006-03-31 $10.36B $4.53B 2.29
2005-12-31 $10.80B $5.72B 1.89
2005-09-30 $11.95B $5.09B 2.35
2005-06-30 $10.95B $6.46B 1.70
2005-03-31 $11.26B $5.38B 2.09
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $108.824B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $344.174B 14.99
Roche Holding AG (RHHBY) Switzerland $241.683B 0.00
Merck (MRK) United States $212.562B 17.48
Pfizer (PFE) United States $201.220B 11.85
Novartis AG (NVS) Switzerland $197.737B 17.02
Novo Nordisk (NVO) Denmark $120.697B 21.33
AstraZeneca (AZN) United Kingdom $114.317B 22.12
Sanofi (SNY) France $111.209B 13.66
AbbVie (ABBV) United States $105.372B 8.44
GlaxoSmithKline (GSK) United Kingdom $102.412B 12.87
Bristol-Myers Squibb (BMY) United States $81.559B 11.57
Bayer (BAYRY) Germany $68.561B 9.99
H Lundbeck (HLUYY) Denmark $6.721B 9.70